No shortage of goserelin drugs in Russia, regulator says
Moscow, October 20. In Russia, drugs based on gozorelin are produced and regularly supplied to the medical network; there is no shortage of them.
Consensus
- There is no shortage of oncology drugs based on goserein in Russia.
- Goserelin-based drugs are being produced in Russia.
- Goserelin-based drugs are being regularly supplied to the medical network.
- The Russian Federal Service for Surveillance in Healthcare (Roszdravnadzor) confirmed this information.
Points of divergence
- Approximately 627,000 packages of drugs with the active ingredient 'Goserelin' were introduced into civil circulation in the first 9.5 months of 2026, compared to about 540,000 packages in the entire 2025 year. — vesti
- A Telegram channel named Mash reported that cancer patients in Russia are at risk of not receiving free goserelin due to reduced supplies caused by the crisis in Europe. — tg_tass_agency
Coverage (2 sources)
- Roszdravnadzor: shortage of oncology drugs based on gozrelin has not been recorded — Вести
- There are no signs of a shortage of oncological drugs based on gozrelin in Russia. They are produced and supplied to the medical network in n... — ТАСС (Telegram)